Tag: #Global Trends

The U.S. Food and Drug Administration (FDA) has officially approved Yartemlea (narsoplimab), marking a historic milestone for the 31-year-old biotech... Read more

Large-scale biologics infrastructure project in Ahmedabad Kashiv BioSciences has secured 648 crore INR (approximately $77 million) in financing from the... Read more

Next-generation electrical pulse therapy Abbott has officially received approval from the U.S. Food and Drug Administration (FDA) for its Volt™... Read more

Transaction to raise ownership to 50% Aurobindo Pharma, through its wholly-owned Dutch subsidiary Helix Healthcare B.V., has reached an agreement... Read more

Commercialization agreement for Nufymco biosimilar Zydus Lifesciences Global FZE, a subsidiary of Zydus, has entered into an agreement with Bioeq... Read more

Reinstating strict pandemic-era protocols Major healthcare systems across states such as Georgia, Ohio, Indiana, and New Jersey have reactivated pandemic-era... Read more

Japanese regulatory authorities have granted marketing approval for 'NIPRO'—a biosimilar referencing Stelara (ustekinumab) developed by Samsung Bioepis—aiming to provide high-quality,... Read more

Pharmaceutical giant AstraZeneca has significantly expanded its partnership with Niowave, securing a decade-long supply of Actinium-225 (Ac-225) to bolster its... Read more

A Baltimore court has issued an unprecedented ruling against Johnson & Johnson (J&J), awarding $1.56 billion to a single plaintiff—the... Read more